Publicación:
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso

dc.contributor.authorBenedetti Padrón, Inésspa
dc.contributor.authorBarrios García, Líaspa
dc.contributor.authorArroyo Salgado, Bárbaraspa
dc.contributor.authorDe Oro, Blancaspa
dc.contributor.authorBeleño, Joséspa
dc.contributor.authorMeza, Mauriciospa
dc.date.accessioned2010-01-15 00:00:00
dc.date.available2010-01-15 00:00:00
dc.date.issued2010-01-15
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2010-2719
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/12870
dc.identifier.urlhttps://doi.org/10.32997/rcb-2010-2719
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2719/2271
dc.relation.citationeditionNúm. 1 , Año 2010spa
dc.relation.citationendpage22
dc.relation.citationissue1spa
dc.relation.citationstartpage10
dc.relation.citationvolume1spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesHumphrey P A, Diagnosis of Adenocarcinoma in prostate needle biopsy tissue, J Cliical Pathology 2007, 60 :35-42spa
dc.relation.referencesParkin DM, Bray F, Ferlay J. et al., Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74–108spa
dc.relation.referencesRegistro de cáncer de Cali 1997, Instituto Nacional de Cancerología 1995-1999spa
dc.relation.referencesAmerican Cancer Society, Inc, Cancer Facts and Figures, Atlanta 2005spa
dc.relation.referencesChodak Gerald, Prostate cancer: epidemiology, screening and biomarkers, Reviews in Urology, Vol 8, Suppl2, S3-S8, 2006spa
dc.relation.referencesShah R.B., M. Zhou, M. LeBlanc, M. Snyder and M.A. Rubin, Comparison of the basal cellspecific markers, 34betaE12 and p63 in the diagnosis of prostate cancer, Am J Surg Pathol 26 (2002), pp. 1161–1168.spa
dc.relation.referencesBoccon-Gibod Liliane et al., Handling and Pathology Reporting of Prostate Biopsies, European Urology, Volume 46 Issue 2, Agosto 2004, Pág 177-181.spa
dc.relation.referencesczkowski A. Kenneth, MacLennan G, Bostwick D, Atypical Small Acinar Proliferation Suspicious for Malignancy in Prostate Needle Byopsies, The American journal of Surgical Pathology, 21(12) 1489-1495, 1997spa
dc.relation.referencesHameed Omar and Humphrey, Immunohistochemistry in the diagnosis of minimal prostate cancer Current diagnostic pathology, Vol 12, Issue 4, Agosto 2006, Pág. 279-291spa
dc.relation.referencesShah Rajal, Lakshmi P Kunju , Shen R, Leblanc M, Zhou M, Rubin M Usefulness of Basal Cell Cocktail (34BE12 + P63) in the Diagnosis of Atypical Prostate Glandular Proliferation, American Journal of Clinical Pathology, 2004; 122(4): 517-523spa
dc.relation.referencesCollins Anne T. AND Maitland Norman J, Prostate cancer stem cells, Europen journal of cancer, Vol 42, Issue 9, Junio 2006, Pág 1213-1218.spa
dc.relation.referencesHedrick Lora, Epstein J, Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma, The American Journal of Surgical Pathology, 13(5): 389-396, 1989spa
dc.relation.referencesEpstein J, Yang X, Prostate Biopsy Interpretation, 2002,spa
dc.relation.referencesYan Gao Man, C Zhao, X Chen, A subset of prostate basal cell lacks the expression of corresponding phenotyping markers, Pathology Research and Practice 202 (2006) 651-662spa
dc.relation.referencesAlgaba F, Epstein JI, Aldape HC, et al., Assessment of prostate carcinoma in core needle biopsy—definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 1996; 78:376–8spa
dc.relation.referencesMontironi Rodolfo et al., 2005 Update on Pathology of Prostate Biopsies with Cancer, European Urology, Vol 49, Issue 3, Marzo 2006, pág 441-447.spa
dc.relation.referencesTotten RS, Heinemann MW, Hudson PB, et al.,Microscopic differential diagnosis of latent carcinoma of prostate. Arch Pathol 1953; 55:131–41.spa
dc.relation.referencesGaudin Paul, Epstein J, Adenosis of the Prostate, The American Journal of Surgical Pathology 18 (9) 863-870, 1994spa
dc.relation.referencesVarma M, Jasani B, Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature, Histopathology 2005, 47, 1-16spa
dc.relation.referencesHameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 2005; 2:88–104spa
dc.relation.referencesZhou Ming, Magi-Galluzi C, Epstein J, Prostate basal cell lesions can be negative for Basal cell Keratins, Analytical and Quantitative Cytology and Histology, Vol 8, Number 3, June 2006spa
dc.relation.referencesBrawer M.K., D.M. Peehl, T.A. Stamey and D.G. Bostwick, Keratin immunoreactivity in the benign and neoplastic human prostate, Cancer Res 45 (1985), pp. 3663–3667.spa
dc.relation.referencesGoldstein N.S., J. Underhill, J. Roszka and J.S. Neill, Cytokeratin 34betaE-12 immunoreactivity in benign prostatic acini: quantitation, pattern assessment, and electron microscopic study, Am J Clin Pathol 112 (1999), pp. 69–74.spa
dc.relation.referencesGown A.M. and A.M. Vogel, Monoclonal antibodies to human intermediate filament proteins, II: distribution of filament proteins in normal human tissues, Am J Pathol 114 (1984), pp. 309–321.spa
dc.relation.referencesHelpap B, J. Kollermann and U. Oehler, Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry, J Pathol 193 (2001), pp. 350–353.spa
dc.relation.referencesKahane H., J.W. Sharp, G.B. Shuman, G. Dasilva and J.I. Epstein, Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory, Urology 45 (1995), pp. 981–986.spa
dc.relation.referencesOkada H., A. Tsubura and A. Okamura et al., Keratin profiles in normal/hyperplastic prostates and prostate carcinoma, Virchows Arch A: Pathol Anat Histopathol 421 (1992), pp. 157–161.spa
dc.relation.referencesSamaratunga H. and M. Singh, Distribution pattern of basal cells detected by cytokeratin 34betaE12 in primary prostatic duct adenocarcinoma, Am J Surg Pathol 21 (1997), pp. 435–440spa
dc.relation.referencesShah I.A., M.O. Schlageter, P. Stinnett and J. Lechago, Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate, Mod Pathol 4 (1991), pp. 220–224.spa
dc.relation.referencesShin M., M.Q. Fujita, Y. Yasunaga, T. Miki, A. Okuyama and K. Aozasa, Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate, Int J Urol 5 (1998), pp. 237–242.spa
dc.relation.referencesWojno K.J. and J.I. Epstein, The utility of basal cell-specific anti-cytokeratin antibody (34betaE12) in the diagnosis of prostate cancer: a review of 228 cases, Am J Surg Pathol 19 (1995), pp. 251–260.spa
dc.relation.referencesZhou M., Z. Jiang and J.I. Epstein, Expression and diagnostic utility of alpha-methylacyl-CoAracemase (P504S) in foamy gland and pseudohyperplastic prostate cancer, Am J Surg Pathol 27 (2003), pp. 772–778spa
dc.relation.referencesDavis L.D, W. Zhang and A. Merseburger et al., p63 expression profile in normal and malignant prostate epithelial cells, Anticancer Res 22 (2002), pp. 3819–3825spa
dc.relation.referencesMolinie V., G. Fromont and M. Sibony et al., Diagnostic utility of a p63 alpha-methyl-CoAracemase (p504s) cocktail in atypical foci in the prostate, Mod Pathol 17 (2004), pp. 1180–1190spa
dc.relation.referencesWeinstein M.H., S. Signoretti and M. Loda, Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells, Mod Pathol 15 (2002), pp. 1302–1308spa
dc.relation.referencesWu H.H., O. Lapkus and M. Corbin, Comparison of 34betaE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies, Appl Immunohistochem Mol Morphol 12 (2004), pp. 285–289.spa
dc.relation.referencesZhou Ming, Shah R, Shen R, Rubin M, Basal Cell Cocktail (34BE12+P63) improves the detection of Prostate Basal Cells, The American Journal of Surgical Pathology 27(3) 365-371, 2003spa
dc.relation.referencesUte M. Moll et al., p53, p63 and p73 – solos, alliances and feuds among family members , Biochimica et biophysica acta, volume 1552 isuue 2:47-59 december 2001spa
dc.relation.referencesFerdinandusse S, S. Denis, L. IJlst, G. Dacremont, H.R. Waterham and R.J. Wanders, Subcellular localization and physiological role of alpha-methylacyl-CoA racemase, J Lipid Res 41 (2000), pp. 1890–1896.spa
dc.relation.referencesXu J, J.A. Stolk and X. Zhang et al., Identification of differentially expressed genes in human prostate cancer using subtraction and microarray, Cancer Res 60 (2000), pp. 1677–1682.spa
dc.relation.referencesZhou M., A.M. Chinnaiyan, C.G. Kleer, P.C. Lucas and M.A. Rubin, Alpha-methylacyl-coA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions, Am J Surg Pathol 26 (2002), pp. 926–931.spa
dc.relation.referencesBeach R, A.M. Gown and M.N. De Peralta-Venturina et al., P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies, Am J Surg Pathol 26 (2002), pp. 1588–1596spa
dc.relation.referencesFarinola M.A., and J.I. Epstein, Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy, Hum Pathol 35 (2004), pp. 1272–1278spa
dc.relation.referencesJiang Z., C. Li, A. Fischer, K. Dresser and B.A. Woda, Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens, Am J Clin Pathol 123 (2005), pp. 231–236spa
dc.relation.referencesJiang Z., C.L. Wu and B.A. Woda et al., P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy, Am J Surg Pathol 26 (2002), pp. 1169–1174spa
dc.relation.referencesKunju L.P, M.A. Rubin, A.M. Chinnaiyan and R.B. Shah, Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations, Am J Clin Pathol 120 (2003), pp. 737-745..spa
dc.relation.referencesMagi-Galluzzi C., J. Luo, W.B. Isaacs, J.L. Hicks, A.M. de Marzo and J.I. Epstein, Alphamethylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy, Am J Surg Pathol 27 (2003), pp. 1128–1133spa
dc.relation.referencesBrowne T.J., M.S. Hirsch, G. Brodsky, W.R. Welch, M.F. Loda and M.A. Rubin, Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens, Hum Pathol 35 (2004), pp. 1462–1468spa
dc.relation.referencesZhou M., H. Aydin, H. Kanane and J.I. Epstein, How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?, Am J Surg Pathol 28 (2004), pp. 239–243spa
dc.relation.referencesAndres M.W., M.A. Amin, T. Freidman, R. Malhotra and A.R. Prasad, Characterization of small foci of atypical glands in prostate needle biopsies using double immunostaining with polyclonal α-methylacyl-CoA racemase and high molecular weight cytokeratin, Mod Pathol 17 (2004), p. 138A.spa
dc.relation.referencesHalushka Marc K. MD, PhD, Negative 34βE12 staining in a small focus of atypical glands on prostate needle biopsy: a follow-up study of 332 cases , Human Pathology, Vol 35, Issue 1,Enero 2004, pág 43-46spa
dc.relation.referencesJiang Z., C.L. Wu and B.A. Woda et al., Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker, Histopathology 45 (2004), pp. 218–225.spa
dc.relation.referencesJiang Z., B.A. Woda and K.L. Rock et al., P504S: a new molecular marker for the detection of prostate carcinoma, Am J Surg Pathol 25 (2001), pp. 1397–1404spa
dc.relation.referencesMing-Tse Sung MD et al., α-methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy, Human Pathology, Vol 38, Issue 2, Febrero 2007, Pág 332-341.spa
dc.relation.referencesJiang Z., K.A. Iczkowski, B.A. Woda, M. Tretiakova and X.J. Yang, P504S immunostaining boosts diagnostic resolution of “suspicious” foci in prostatic needle biopsy specimens, Am J Clin Pathol 121 (2004), pp. 99–107spa
dc.relation.referencesVarma M, M.D. Linden and M.B. Amin, Effect of formalin fi xation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues, Mod Pathol 12 (1999), pp. 472–478spa
dc.relation.referencesGreen R, and Epstein J, Use of intervening unstained slides for inmunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies,,Am J Surg Pathol 1999,23 (5): 567-570spa
dc.relation.referencesVan Der Kwast et al, Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies, (Am J Surg Pathol 2010; 34: 169–177spa
dc.relation.referencesO’Malley F.P., D.J. Grignon and D.T. Shum, Usefulness of immunoperoxidase staining with highmolecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland, Virchows Arch A: Pathol Anat Histopathol 417 (1990), pp. 191–196.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2719spa
dc.subjectAdenocarcinoma prostáticospa
dc.subjectCélulas basalesspa
dc.subject34BE12spa
dc.subjectp63spa
dc.subjectspa
dc.titleDeterminación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudosospa
dc.title.translatedDeterminación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudosoeng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: